Clinical Trial Update: Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on stopping levothyroxine therapy in patients with subclinical hypothyroidism; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subclinical Hypothyroidism

Drugs mentioned

• Levothyroxine (levothyroxine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Subclinical Hypothyroidism | Phase 4 | Status: COMPLETED | Results posted: 2023-11-18